Rhizome AI

0 reviews

Rhizome AI is a generative AI platform that transforms how biotech and life sciences teams access and interpret regulatory and clinical information. It allows users to instantly find what the FDA, EMA, and other health authorities have said about therapies, approvals, and trials, delivering verified insights in seconds instead of days. The platform integrates data from FDA and EMA pre-approval therapeutics databases, CTIS, ClinicalTrials.gov, and other key sources. All data is refreshed at the same cadence as regulators, ensuring accuracy and timeliness. Every answer in Rhizome AI is fully traceable; users can click to view the original PDF, HTML page, or text file, enabling transparent, evidence-based decision-making. By combining regulatory intelligence, clinical data aggregation, and generative AI, Rhizome AI helps organizations accelerate R&D, streamline compliance, and make faster, more informed strategic decisions across the biotech lifecycle.